SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Amendment to Transaction

13 Mar 2007 10:56

Thistle Mining Inc.13 March 2007 THISTLE MINING INC. Thistle Announces Amendment to Transaction with CGA Mining Limited Regarding Thistle's Masbate Gold Project Toronto, March 13, 2007: Thistle Mining Inc ("Thistle") (AIM:TMG) announcedtoday that it has agreed with CGA Mining Limited (formerly Central Asia GoldLimited) ("CGA") (ASX: CGX and TSX:CGA) to amend the terms of the agreementdated January 31, 2007 (the "Original SPA") pursuant to which CGA, through awholly-owned subsidiary of CGA (the "Purchaser"), agreed to purchase 100% of theshares of Philippine Gold Ltd, a wholly-owned subsidiary of Thistle, andThistle's other interests in the Masbate gold project (the "Transaction")subject to the terms and conditions set out in the Original SPA. Pursuant to the Original SPA, the consideration payable by the Purchaser is, inaggregate, US$51 million (the "Purchase Consideration") of which US$21 millionis payable in ordinary shares of CGA (the "CGA Shares"). The issue price of theCGA Shares was to be based on the lesser of A$0.65 per share and the volumeweighted average price at which the CGA Shares were traded on the AustralianStock Exchange (the "ASX") in the 10 consecutive trading days ("10 Day VWAP")immediately prior to the completion date of the Transaction ("Completion Date").As a result of the recent market volatility, Thistle and CGA have agreed toamend the Original SPA to provide that the issue price of the CGA Shares will befixed at A$0.65 per CGA Share (the "Revised Formula"), which could be higher orlower than the market price of the CGA Shares on the ASX at the Completion Date.It is expected that all other terms and conditions of the Original SPA,including the Purchase Consideration, will remain unchanged. As at the close ofbusiness in Australia on March 12, 2007, the 10 Day VWAP for the CGA Shares wasA$0.6237 which, under the formula contained in the Original SPA, would haveresulted in Thistle receiving 42,973,878 CGA Shares worth US $21.00 million(based on a conversion rate for the A$ to the United States dollar of US$0.7835)if the Completion Date were March 13, 2007. Under the Revised Formula, Thistlewould have received 41,235,089 CGA Shares worth US $20.15 million. A meeting of Thistle's shareholders to consider the Transaction is scheduled forMarch 16, 2007 (the "Meeting"). Thistle shareholders will be asked to approvethe Original SPA, as amended, which approval will be conditional upon the 10 DayVWAP of the CGA Shares being not less than A$0.60 per share in the 10consecutive trading days immediately prior to the completion date of theTransaction. The Board of Directors of Thistle continues to recommend thatThistle shareholders vote in favour of the Transaction. In the event that theVWAP falls below A$0.60 per share the Board of Directors will review theCompany's position and will consider whether or not it is in the best interestsof the Company to proceed with the transaction in accordance with any approvalgranted by Thistle shareholders at the Meeting and all rules and regulationsapplicable to the Company. A notice of the Meeting and a circular containing additional details withrespect to the Transaction were mailed to Thistle shareholders in mid-February(the "Meeting Materials"). The Meeting Materials noted the proxy cut-off timefor voting at the Meeting as 48 hours prior to the Meeting; however, as a resultof the foregoing amendment to the Original SPA, Thistle has agreed to extend thecut-off time to 9:00 a.m. (Toronto time) on March 16, 2007, the day of theMeeting. Thistle shareholders are reminded that, if they have already submitteda proxy and wish to change the instructions provided therein, a new proxy can besubmitted to CIBC Mellon Trust Company ("CIBC Mellon") in accordance with theinstructions provided in the form of proxy. Blank proxies are available onThistle's SEDAR filing page at www.SEDAR.com. If submitting a revised proxy,Thistle shareholders should ensure that they clearly write their name as itappears on Thistle's registered list of shareholders on the form of proxy. IfThistle shareholders have already submitted a proxy and do not wish to changethe instructions provided therein, no further action is required. Thistleshareholders are also reminded that proxies can be submitted by fax to Thistle'stransfer agent, CIBC Mellon, at fax 416-368-2502. A meeting of the shareholders of CGA to consider the Transaction is scheduledfor March 16, 2007 in Australia. Assuming the shareholders of each of CGA andThistle approve the Transaction and all other conditions to the completion aresatisfied or waived, Thistle expects that the Transaction will be completed byMarch 30, 2007. For further information, contact: β€’ Andy Graetz, Chief Financial Officer at + 27 82 929 5562 or email to agraetz@disselgroup.com; or β€’ Gerry Beaney, Grant Thornton Corporate Finance at +44 (0) 207 383 5100. Forward Looking Information: This press release may contain or refer toforward-looking information based on current expectations. Forward-lookingstatements are subject to significant risks and uncertainties, and other factorsthat could cause actual results to differ materially from expected results.These forward-looking statements are made as of the date hereof and Thistleassumes no responsibility to update or revise them to reflect new events orcircumstances. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Sep 20217:00 amRNSInterim Results for six months to 30 June 2021
14th Jul 20217:00 amRNSTRADING UPDATE AND NOTICE OF INTERIM RESULTS
28th Jun 20217:00 amRNSGrowth Share Scheme
25th Jun 20212:17 pmRNSHolding(s) in Company
15th Jun 20217:00 amRNSDirector/PDMR Shareholding
14th Jun 20211:38 pmRNSResult of AGM
14th Jun 20217:00 amRNSTR1: Notification of Major Holdings
11th May 20219:19 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirectorate Changes
26th Apr 20215:05 pmRNSCorrection: Director/PDMR Shareholding
26th Apr 202112:15 pmRNSDirector/PDMR Shareholding
19th Apr 20216:04 pmRNSDirector/PDMR Shareholding
14th Apr 20217:01 amRNSFinal Results for the Year Ended 31 December 2020
14th Apr 20217:00 amRNSChanges to the Board
11th Mar 20214:40 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSHolding(s) in Company
22nd Feb 20215:37 pmRNSDirector/PDMR Shareholding
9th Feb 20219:24 amRNSDirector/PDMR Shareholding
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSTrading Update and Notice of Results
11th Nov 20204:58 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results
27th Jul 20207:00 amRNSACQUISITION OF INNOVATIONBUBBLE
15th Jul 20207:00 amRNSTrading Statement and Notice of Interim Results
15th Jun 20203:37 pmRNSResult of AGM
21st May 20207:00 amRNSCovid-19 and AGM Update
11th May 20204:58 pmRNSDirector Dealing and Issue of Consideration Shares
17th Apr 20203:36 pmRNSIssue of Equity
7th Apr 20205:00 pmRNSPDMR Shareholding pursuant to Growth Share Scheme
1st Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
27th Mar 20205:22 pmRNSCOVID-19 UPDATE
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
13th Mar 20202:22 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
9th Dec 201911:55 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSLaunch of Global Competition
25th Sep 20197:00 amRNSChange of Name
25th Sep 20197:00 amRNSHalf-year Report
13th Aug 20197:00 amRNSEBT Share Dealings
7th Aug 20198:15 amRNSEBT Share Dealings
1st Aug 20191:11 pmRNSDirector/PDMR Shareholding - Replacement
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
15th Jul 20197:00 amRNSTrading Update
17th Jun 201912:57 pmRNSResult of AGM
17th Jun 201911:58 amRNSBoard Changes
12th Jun 20195:26 pmRNSDirector/PDMR Shareholding
7th Jun 20199:34 amRNSEBT Share Dealings
6th Jun 20191:17 pmRNSEBT Share Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.